Michael Peluso, Md
Clinical trials sponsored by Michael Peluso, Md, explained in plain language.
-
Could a single drug replace daily HIV pills? new study aims to find out.
Disease control ENROLLING_BY_INVITATIONThis study tests whether a drug called N-803 (IL-15) can boost the immune system to control HIV without daily antiretroviral therapy. About 20 adults with well-controlled HIV will receive the drug or a placebo, then temporarily stop their regular HIV meds to see if the virus stay…
Phase: PHASE2 • Sponsor: Michael Peluso, MD • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Could an antibody ease long COVID? new study begins
Symptom relief OngoingThis study tests whether a lab-made antibody called AER002 can safely help adults with Long COVID feel better. Long COVID may be caused by leftover virus in the body, and this antibody aims to target that virus. 36 participants will receive either the antibody or a placebo, and r…
Phase: PHASE2 • Sponsor: Michael Peluso, MD • Aim: Symptom relief
Last updated May 07, 2026 18:41 UTC